This is particularly interesting since recent evidence suggests that proteolytic cleavage of vitronectin is enhanced in HCC to yield high soluble levels of a vitronectin fragment in the serum, which can be used as a marker of disease progression (Paradis et al, 2005). The gene discussed is VTN; the disease is hepatocellular carcinoma.